Guerra Pan Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Guerra Pan Advisors's VRTX Position: Q1 2026 in Review
Guerra Pan Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 1.5% in Q1 2026, buying an estimated $3.26K and bringing the position to 485 shares worth $217K. The position accounts for 0.13% of the portfolio, ranked #112.
Guerra Pan Advisors first reported a position in VRTX in Q2 2024 and has held it in 7 quarters since. The position peaked at $303K in Q2 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Guerra Pan Advisors held 485 shares of Vertex Pharmaceuticals worth $217K as of Q1 2026.
- Guerra Pan Advisors bought 7 Vertex Pharmaceuticals shares in Q1 2026, an estimated $3.26K.
- Vertex Pharmaceuticals made up 0.13% of Guerra Pan Advisors's portfolio in Q1 2026, its #112 holding.
- Guerra Pan Advisors first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
- Guerra Pan Advisors's Vertex Pharmaceuticals position peaked at $303K in Q2 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Guerra Pan Advisors's 13F filing for Q1 2026, filed 12 May 2026.